Evidence map›Paper›PMID 25392729›Full record

ArticleMolecular autism2014

The Autism Simplex Collection: an international, expertly phenotyped autism sample for genetic and phenotypic analyses.

Joseph D Buxbaum, Nadia Bolshakova, Jessica M Brownfeld, Richard Jl Anney, Patrick Bender, Raphael Bernier, Edwin H Cook, Hilary Coon, Michael Cuccaro, Christine M Freitag and 14 more

Abstract read
In one paragraph

Article in Molecular autism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lovastatin Treatment of a Patient with aJournal of child and adolescent psychopharmacology · 2019
    Article
  10. Brief Report: The Negev Hospital-University-Based (HUB) Autism Database.Journal of autism and developmental disorders · 2017
    Article
  11. Article
  12. Article
  13. Bio-collections in autism research.Molecular autism · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Joseph D BuxbaumThe Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Nadia BolshakovaAutism Genetics Group, Department of Psychiatry, School of Medicine, Trinity College, Dublin 8, Ireland.
Jessica M BrownfeldThe Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Richard Jl AnneyAutism Genetics Group, Department of Psychiatry, School of Medicine, Trinity College, Dublin 8, Ireland.
Patrick BenderNational Institute of Mental Health (NIMH), Bethesda, MD 20892-9663, USA.
Raphael BernierDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA.
Edwin H CookInstitute for Juvenile Research, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60608, USA.
Hilary CoonPsychiatry Department, University of Utah Medical School, Salt Lake City, UT 84108, USA.
Michael CuccaroThe John P Hussman Institute for Human Genomics, University of Miami, Miami, FL 33101, USA.
Christine M FreitagDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, JW Goethe University Frankfurt, 60528 Frankfurt, Germany.
Joachim HallmayerDepartment of Psychiatry and Behavioral Science, Child and Adolescent Psychiatry, Stanford School of Medicine, Stanford, CA, USA.
Daniel GeschwindDepartment of Neurology, University of California at Los Angeles, School of Medicine, Los Angeles, CA 90095, USA.
Sabine M KlauckGerman Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
John I NurnbergerDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Guiomar OliveiraUnidade de Neurodesenvolvimento e Autismo do Serviço do Centro de Desenvolvimento da Criança and Centro de Investigação e Formação Clinica, Pediatric Hospital, Centro Hospitalar e Universitário de Coimbra, 3000-602 Coimbra, Portugal ; University Clinic of Pediatrics and Institute for Biomedical Imaging and Life Science, Faculty of Medicine, University of Coimbra, 3000-602 Coimbra, Portugal.
Dalila PintoThe Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Fritz PoustkaDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, JW Goethe University Frankfurt, 60528 Frankfurt, Germany.
Stephen W SchererDepartment of Molecular Genetics, The Centre for Applied Genomics, Hospital for Sick Children and McLaughlin Centre and University of Toronto, Toronto, ON, Canada.
Andy ShihAutism Speaks, New York, NY 10016, USA.
James S SutcliffeDepartment of Molecular Physiology and Biophysics, Vanderbilt Kennedy Center, Vanderbilt University, Nashville, TN 37232, USA ; Centers for Human Genetics Research and Molecular Neuroscience, Vanderbilt University, Nashville, TN 37232, USA.
Peter SzatmariDepartment of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Astrid M VicenteInstituto Nacional de Saúde Dr Ricardo Jorge, 1649-016 Lisbon, Portugal ; Instituto Gulbenkian de Ciência, P-2781-901 Oeiras, Portugal ; BioFIG-Center for Biodiversity, Functional & Integrative Genomics, Campus da FCUL, C2.2.12, Campo Grande, 1749-016 Lisboa, Portugal.
Veronica VielandThe Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
Louise GallagherAutism Genetics Group, Department of Psychiatry, School of Medicine, Trinity College, Dublin 8, Ireland.

Funding

Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
1/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomesU01MH100233 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUXBAUM, JOSEPH D. · 2013 to 2015
$2.5M
1/3 - Sequencing Autism Spectrum Disorder Extended PedigreesR01MH094400 · NIMH · UNIVERSITY OF UTAH · PI COON, HILARY · 2012 to 2016
$1.5M
NICHD NIH HHS U54 HD083091NIMH NIH HHS R01 MH094400NIMH NIH HHS U01 MH100233
6 · The paper itself

Abstract

backgroundThere is an urgent need for expanding and enhancing autism spectrum disorder (ASD) samples, in order to better understand causes of ASD.

methodsIn a unique public-private partnership, 13 sites with extensive experience in both the assessment and diagnosis of ASD embarked on an ambitious, 2-year program to collect samples for genetic and phenotypic research and begin analyses on these samples. The program was called The Autism Simplex Collection (TASC). TASC sample collection began in 2008 and was completed in 2010, and included nine sites from North America and four sites from Western Europe, as well as a centralized Data Coordinating Center.

resultsOver 1,700 trios are part of this collection, with DNA from transformed cells now available through the National Institute of Mental Health (NIMH). Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule-Generic (ADOS-G) measures are available for all probands, as are standardized IQ measures, Vineland Adaptive Behavioral Scales (VABS), the Social Responsiveness Scale (SRS), Peabody Picture Vocabulary Test (PPVT), and physical measures (height, weight, and head circumference). At almost every site, additional phenotypic measures were collected, including the Broad Autism Phenotype Questionnaire (BAPQ) and Repetitive Behavior Scale-Revised (RBS-R), as well as the non-word repetition scale, Communication Checklist (Children's or Adult), and Aberrant Behavior Checklist (ABC). Moreover, for nearly 1,000 trios, the Autism Genome Project Consortium (AGP) has carried out Illumina 1 M SNP genotyping and called copy number variation (CNV) in the samples, with data being made available through the National Institutes of Health (NIH). Whole exome sequencing (WES) has been carried out in over 500 probands, together with ancestry matched controls, and this data is also available through the NIH. Additional WES is being carried out by the Autism Sequencing Consortium (ASC), where the focus is on sequencing complete trios. ASC sequencing for the first 1,000 samples (all from whole-blood DNA) is complete and data will be released in 2014. Data is being made available through NIH databases (database of Genotypes and Phenotypes (dbGaP) and National Database for Autism Research (NDAR)) with DNA released in Dist 11.0. Primary funding for the collection, genotyping, sequencing and distribution of TASC samples was provided by Autism Speaks and the NIH, including the National Institute of Mental Health (NIMH) and the National Human Genetics Research Institute (NHGRI).

conclusionsTASC represents an important sample set that leverages expert sites. Similar approaches, leveraging expert sites and ongoing studies, represent an important path towards further enhancing available ASD samples.

Identifiers

PMID25392729
PMCPMC4228819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.